We are live on ! Find out more
ACER

Acer Therapeutics Inc

Delisted

ACER was delisted on the 8th of November, 2023.

30 hedge funds and large institutions have $5.15M invested in Acer Therapeutics Inc in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3030 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

7% less call options, than puts

Call options by funds: $150K | Put options by funds: $162K

23% less capital invested

Capital invested by funds: $6.67M → $5.15M (-$1.52M)

Holders
30
Holders Change
Holders Change %
0%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
7
Reduced
7
Closed
7
Calls
$150K
Puts
$162K
Net Calls
-$12K
Net Calls Change
+$1K
Name Holding Trade Value Shares
Change
Change in
Stake
BNP Paribas Financial Markets
26
BNP Paribas Financial Markets
France
$557
JGC
27
J. Goldman & Co
New York
-$943K -360,000 Closed
ACM
28
AIGH Capital Management
Maryland
-$656K -250,518 Closed
WVP
29
Worth Venture Partners
New Jersey
-$656K -250,518 Closed
Federated Hermes
30
Federated Hermes
Pennsylvania
-$299K -114,091 Closed
HAG
31
HighPoint Advisor Group
Illinois
-$113K -29,205 Closed
Two Sigma Investments
32
Two Sigma Investments
New York
-$34K -12,872 Closed
Wells Fargo
33
Wells Fargo
California
+$54 +16 +55%
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
+$340 +100 New

ACER Hedge Fund Activity: Q1 2021 in Review

30 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q1 2021, worth a combined $5.15M — down 23% from $6.67M a quarter earlier.

Fund positioning in ACER was balanced in Q1 2021: 7 funds opened new positions, 7 closed out, 7 added to existing stakes and 7 trimmed.

The largest buyer was Squarepoint, opening a new position worth an estimated $255K. The largest seller was J. Goldman & Co, exiting entirely with an estimated $943K sold.

  • 30 institutional investors held Acer Therapeutics Inc (ACER) as of Q1 2021, unchanged from Q4 2020.
  • Funds reported $5.15M of Acer Therapeutics Inc stock for Q1 2021, down 23% quarter-over-quarter.
  • 7 funds opened new Acer Therapeutics Inc positions in Q1 2021 and 7 closed out, a net change of 0 holders.
  • The largest Acer Therapeutics Inc buyer in Q1 2021 was Squarepoint, an estimated $255K added.
  • The largest Acer Therapeutics Inc seller in Q1 2021 was J. Goldman & Co, an estimated $943K sold.

Based on aggregated 13F filings for Q1 2021.